Caspase inhibitor Q-VD-OPh hydrate, Purity ≥98%

Synonym: 1135695-98-5; Q-VD-OPh; Q-VD-OPh hydrate; QVD-OPH; (3S)-5-(2,6-Difluorophenoxy)-3-[[(2S)-3-methyl-2-(quinoline-2-carbonylamino)butanoyl]amino]-4-oxopentanoic acid; Caspase inhibitor

MDL: MFCD08669741
CAS Number: 1135695-98-5
Compound CID: 24794416

Product Size

5 mg; 10 mg; 25 mg; 50 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Q-VD-OPh hydrate, soluble in DMSO and ethanol and insoluble in water, inhibits the activity of caspases, thereby preventing apoptosis. It targets Caspase-1, Caspase-3, Caspase-8, and Caspase-9.

Molecular Weight

513.49

Molecular Formula

C₂₆H₂₅F₂N₃O₆

Targets

Caspase-1: 25-400 nM; Caspase-3: 25-400 nM; Caspase-8: 25-400 nM; Caspase-9: 25-400 nM

Form

Lyophilized powder

Purity

≥98%

Solubility

DMSO: 94 mg/mL (183.06 mM); Water: Insoluble; Ethanol: 94 mg/mL (183.06 mM)

Identity

Confirmed by NMR/HPLC/MS.

Stability

The product is stable for three years when stored at the recommended temperature in lyophilized powder.

Applications

Q-VD-OPh hydrate can be used as a broad-spectrum caspase inhibitor in apoptosis research.

Storage

Store at -20ºC.